Literature DB >> 7715738

Chronic muscarinic cholinoceptor stimulation increases adenylyl cyclase responsiveness in rat cardiomyocytes by a decrease in the level of inhibitory G-protein alpha-subunits.

C Reithmann1, K Werdan.   

Abstract

Exposure of neonatal rat cardiomyocytes for 3 days to the muscarinic cholinoceptor agonist carbachol led to a concentration-dependent increase in adenylyl cyclase stimulation by the beta-adrenoceptor agonist isoproterenol by up to 115% (at 1 mmol/l carbachol). In addition, direct adenylyl cyclase stimulation by forskolin was increased in carbachol (1 mmol/l)-treated cells by 32%. Pretreatment of the rat cardiomyocytes with pertussis toxin, which enhances adenylyl cyclase activity by a functional inactivation of the inhibitory G-protein (Gi), was performed to investigate the possible role of Gi-proteins in carbachol-induced sensitization of adenylyl cyclase stimulation. After pretreatment of the cells with pertussis toxin, the carbachol-mediated increase in forskolin-stimulated adenylyl cyclase activity was lost and the carbachol-mediated increase in beta-adrenoceptor-stimulated adenylyl cyclase activity was attenuated. Labelling of the 40 kDa pertussis toxin substrates in cardiomyocyte membranes was decreased by carbachol in a concentration-dependent manner by up to 34% (at 1 mmol/l carbachol). The number and affinity of beta 1-adrenoceptors was unaltered following the chronic carbachol treatment. The specific protein synthesis inhibitor Pseudomonas exotoxin A was used to study whether the carbachol-induced decrease in the level of pertussis toxin-sensitive G-proteins and increase in adenylyl cyclase activity depend on de-novo protein synthesis. Pseudomonas exotoxin A inhibits peptide chain elongation by ADP-ribosylating elongation factor 2. Treatment of the cells with 1 ng/ml Pseudomonas exotoxin A for 3 days led to a reduction in the subsequent ADP-ribosylation of elongation factor 2 in the cytosol of the heart muscle cells by 57%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715738     DOI: 10.1007/BF00169060

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.195


  30 in total

Review 1.  Agonist control of G-protein levels.

Authors:  G Milligan; A Green
Journal:  Trends Pharmacol Sci       Date:  1991-06       Impact factor: 14.819

Review 2.  The parasympathetic neuroeffector junction of the heart.

Authors:  K Löffelholz; A J Pappano
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468

3.  Intrinsic sympathomimetic activity of beta-adrenoceptor antagonists: down-regulation of cardiac beta 1- and beta 2-adrenoceptors.

Authors:  C Reithmann; F Wieland; K H Jakobs; K Werdan
Journal:  Eur J Pharmacol       Date:  1989-11-07       Impact factor: 4.432

4.  Beta-adrenergic receptor sensitivity and guanine nucleotide regulatory proteins in transplanted human hearts and autotransplanted baboons.

Authors:  E M Horn; P Danilo; M A Apfelbaum; M L Barr; P Pepino; E R Powers; C R Smith; E A Rose; J P Bilezikian
Journal:  Transplantation       Date:  1991-12       Impact factor: 4.939

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  GTP-dependent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agonists.

Authors:  K H Jakobs; K Aktories; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

7.  Alpha 1-adrenergic and muscarinic cholinergic stimulation of phosphoinositide hydrolysis in adult rat cardiomyocytes.

Authors:  J H Brown; I L Buxton; L L Brunton
Journal:  Circ Res       Date:  1985-10       Impact factor: 17.367

8.  Heterologous desensitization of the inhibitory A1 adenosine receptor-adenylate cyclase system in rat adipocytes. Regulation of both Ns and Ni.

Authors:  W J Parsons; G L Stiles
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

9.  M1 muscarinic receptors increase calcium current and phosphoinositide turnover in guinea-pig ventricular cardiocytes.

Authors:  M P Gallo; G Alloatti; C Eva; A Oberto; R C Levi
Journal:  J Physiol       Date:  1993-11       Impact factor: 5.182

10.  The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates.

Authors:  J B Galper; L C Dziekan; D S O'Hara; T W Smith
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

View more
  5 in total

1.  Cross-regulation between cardiac muscarinic acetylcholine receptors and β-adrenoceptors: lessons for use of knock-out mice.

Authors:  Stefan Dhein; Sandy von Salisch; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-10       Impact factor: 3.000

2.  Differential nature of cross-talk among three G-coupled receptors regulating adenylyl cyclase in rat cardiomyocytes chronically exposed to receptor agonists.

Authors:  P V Sulakhe; X T Vo; R R Mainra
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

3.  Non-classical regulation of β1- and β 2-adrenoceptor-mediated inotropic responses in rat heart ventricle by the G protein Gi.

Authors:  Caroline Bull Melsom; Rizwan Iqbal Hussain; Øivind Ørstavik; Jan Magnus Aronsen; Ivar Sjaastad; Tor Skomedal; Jan-Bjørn Osnes; Finn Olav Levy; Kurt Allen Krobert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-09-13       Impact factor: 3.000

4.  RGS3L allows for an M2 muscarinic receptor-mediated RhoA-dependent inotropy in cardiomyocytes.

Authors:  Susanne Lutz; Thomas Wieland; Magdolna K Levay; Kurt A Krobert; Andreas Vogt; Atif Ahmad; Andreas Jungmann; Christiane Neuber; Sebastian Pasch; Arne Hansen; Oliver J Müller
Journal:  Basic Res Cardiol       Date:  2022-03-01       Impact factor: 12.416

5.  Gi proteins regulate adenylyl cyclase activity independent of receptor activation.

Authors:  Caroline Bull Melsom; Øivind Ørstavik; Jan-Bjørn Osnes; Tor Skomedal; Finn Olav Levy; Kurt Allen Krobert
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.